These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3654954)

  • 21. [Enzymatic activities of Campylobacter jejuni, C. coli, and C. lari].
    Colomina J; Villar J; Buesa J; Borras R
    Rev Argent Microbiol; 1997; 29(2):68-74. PubMed ID: 9424627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of nalidixic acid resistant Campylobacters from cases of paediatric diarrhoea in Chennai.
    Ananthan S; Swarna SR; Alavandi SV
    J Commun Dis; 1998 Sep; 30(3):159-62. PubMed ID: 10093421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and antimicrobial susceptibility of Campylobacter coli and Campylobacter jejuni from slaughter hogs.
    Hariharan H; Wright T; Long JR
    Microbiologica; 1990 Jan; 13(1):1-6. PubMed ID: 2308529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A one-year study on thermophilic campylobacters isolated from fecal specimens.
    Varoli O; Gatti M; Piscolla F
    Microbiologica; 1989 Jul; 12(3):263-5. PubMed ID: 2674635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
    Pasquali F; Lucchi A; Manfreda G
    Int J Antimicrob Agents; 2008 May; 31(5):500-2. PubMed ID: 18329250
    [No Abstract]   [Full Text] [Related]  

  • 26. Campylobacter laridis causing bacteremia in an immunosuppressed patient.
    Nachamkin I; Stowell C; Skalina D; Jones AM; Hoop RM; Smibert RM
    Ann Intern Med; 1984 Jul; 101(1):55-7. PubMed ID: 6375505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to erythromycin in fluoroquinolone-resistant Campylobacter jejuni strains isolated from human faeces.
    Reina J; Ros MJ; Fernandez-Baca V
    J Antimicrob Chemother; 1995 Feb; 35(2):351-2. PubMed ID: 7759401
    [No Abstract]   [Full Text] [Related]  

  • 28. [A man with Campylobacter endocarditis, treatable as Campylobacter fetus following identification].
    Ang CW; Endtz HP; Kuijper EJ
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1384; author reply 1384-5. PubMed ID: 12892017
    [No Abstract]   [Full Text] [Related]  

  • 29. Susceptibility of Campylobacter fetus subsp. jejuni, isolated from patients in Jakarta, Indonesia to ten antimicrobial agents.
    Ringertz S; Rockhill RC; Ringertz O
    J Antimicrob Chemother; 1981 Oct; 8(4):333-6. PubMed ID: 7298551
    [No Abstract]   [Full Text] [Related]  

  • 30. Two simultaneous cases of disseminated infections with Campylobacter fetus: clinical characteristics and molecular comparison.
    Durovic A; Seth-Smith HMB; Hinic V; Kurz M; Khanna N; Egli A
    Clin Microbiol Infect; 2021 Jan; 27(1):141-143. PubMed ID: 32717414
    [No Abstract]   [Full Text] [Related]  

  • 31. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team.
    Smith KE; Besser JM; Hedberg CW; Leano FT; Bender JB; Wicklund JH; Johnson BP; Moore KA; Osterholm MT
    N Engl J Med; 1999 May; 340(20):1525-32. PubMed ID: 10332013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antimicrobial susceptibility, plasmid analysis, and serotyping of epidemic-associated Campylobacter jejuni.
    Bopp CA; Birkness KA; Wachsmuth IK; Barrett TJ
    J Clin Microbiol; 1985 Jan; 21(1):4-7. PubMed ID: 3968203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates.
    Karmali MA; De Grandis S; Fleming PC
    Antimicrob Agents Chemother; 1981 Apr; 19(4):593-7. PubMed ID: 7247381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of quinolone-resistant Campylobacter fetus bacteremia in human immunodeficiency virus-infected patients.
    Meier PA; Dooley DP; Jorgensen JH; Sanders CC; Huang WM; Patterson JE
    J Infect Dis; 1998 Apr; 177(4):951-4. PubMed ID: 9534967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients.
    Sjögren E; Lindblom GB; Kaijser B
    J Antimicrob Chemother; 1997 Aug; 40(2):257-61. PubMed ID: 9301992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid emergence of quinolone resistance in Campylobacter jejuni in patients treated with norfloxacin.
    Wretlind B; Strömberg A; Ostlund L; Sjögren E; Kaijser B
    Scand J Infect Dis; 1992; 24(5):685-6. PubMed ID: 1465591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and immunogenicity of Campylobacter fetus subsp. fetus from an abdominal aortic aneurysm.
    Grollier G; Burucoa C; Ricco JB; Pezennec L; Fauchère JL
    Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):847-9. PubMed ID: 8112355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Campylobacter fetus subsp. jejuni: etiological, epidemiological and preventive aspects].
    Serafini G; Caramello S; Maggi C
    G Batteriol Virol Immunol; 1984; 77(1-6):63-85. PubMed ID: 6536547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of high-level quinolone resistance in Campylobacter jejuni.
    Gootz TD; Martin BA
    Antimicrob Agents Chemother; 1991 May; 35(5):840-5. PubMed ID: 1649570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotyping and antibiotic resistance patterns of Campylobacter fetus subsp.venerealis from cattle farms in India.
    Ishtifaq A; Qureshi S; Farooq S; Kashoo ZA; Malik MZ; Alam MR; Wani SA; Bhat MA; Hussain MI; Dar RA; Shah SM
    Lett Appl Microbiol; 2020 Dec; 71(6):627-636. PubMed ID: 32867004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.